Anti-CD14, Recombinant [UCH-M1]
Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields
- Datasheet
- References (1)
- Inventor Info
Info
| Catalogue Number | 153280 |
| Applications | FACS IHC IF |
| Antigen/Gene or Protein Targets | CD14 |
| Synonyms | CD14 Molecule; CD14 Antigen; Myeloid Cell-Specific Leucine-Rich Glycoprotein |
| Reactivity | Human |
| Relevance | CD14 is found in human monocytes and vascular endothelium in some tissues. CD14 binds the endotoxin lipopolysaccharide. UCH-M1 can be used to investigate specific in vitro antibody responses to influenza virus by human lymphocytes. |
| Host | Mouse |
| Immunogen | Thymocytes and peripheral blood leucocytes (PBL) |
| Subclass | IgG2a |
| Formulation | PBS |
| Concentration | 1mgml-1 |
| Research Area | Immunology |
| Notes |
Recombinant monoclonal antibody produced from the original monoclonal cell line. Manufactured using Absolute Antibody’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma. Six products based on this clone: - Anti-CD14 [UCH-M1], Mouse IgG2a, Kappa - Anti-CD14 [UCH-M1], Mouse IgG2a, Kappa, engineered Fc domain containing key point mutations that abrogate binding to Fc gamma receptors - Anti-CD14 [UCH-M1], Rabbit IgG, Kappa - Anti-CD14 [UCH-M1], Human IgG4-S228P, Kappa - Anti-CD14 [UCH-M1], Human IgG1, Kappa - Anti-CD14 [UCH-M1], Human IgG1, Kappa, engineered Fc domain containing key point mutations that abrogate binding to Fc gamma receptors |
References: 1 entry
Original hybridoma first published in: Mitchell et al. 1983. Immunology. 50(2):239-50. PMID: 6578194.
Add a reference
References: 1 entry
Original hybridoma first published in: Mitchell et al. 1983. Immunology. 50(2):239-50. PMID: 6578194.
Add a reference
